small molecule

PIZENSY

LACTITOL

Loss of exclusivityMay 2037latest FDA-listed patent expiry
CompanyBraintreeSee this company's full patent-cliff portfolio

Drug detail

Brand namePIZENSY
Active ingredientLACTITOL
Strength10GM
Dosage formFOR SOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 2020
Marketing statusDISCN

Listed patents

PatentExpiresType
10806743May 2037use U-1516

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

PIZENSY patent cliff — loss of exclusivity May 2037 | CliffBio